METASTATIC PROSTATE ADENOCARCINOMA
Clinical trials for METASTATIC PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial halted for new prostate cancer drug combo
Disease control TerminatedThis early-stage study aimed to test the safety of an experimental immunotherapy drug called vudalimab when given alongside standard prostate cancer treatments. It involved a small group of men whose prostate cancer had spread but was still sensitive to hormone-blocking therapy. …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Drug trial halted early for advanced prostate cancer
Disease control TerminatedThis study tested whether a drug called erdafitinib could help control advanced prostate cancer that had stopped responding to standard hormone treatments and spread to the bones. It involved 11 men and aimed to see if the drug could slow cancer growth and reduce bone-related mar…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Targeted radiation tested to ease agony of cancer in bones
Symptom relief TerminatedThis study tested an experimental radioactive drug designed to target and treat cancer that has spread to the bones from prostate cancer. The main goal was to see if the treatment could provide lasting relief from the severe bone pain caused by these metastases. The trial was ter…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC